SR

Shiv Raj Singh

Active Director Director DIN 09359510
DIN 09359510 First appointment Nov 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value •••• Premium profile

About Shiv Raj Singh

Data last updated:

Shiv Raj Singh is a Director at Devann Pharmaceuticals Private Limited (since 2021). The company operates in Healthcare. Devann Pharmaceuticals Private Limited reported revenue of ₹22.7 Lakh (FY 2025).

DIN 09359510
Primary Designation Director
Industry Healthcare
First Appointment 10 Nov 2021
Oldest Company Age 6 yrs
Largest company Devann Pharmaceuticals Private Limited · ₹22.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Nov 20212020₹22.7 Lakh (FY 2025)Active

Board colleagues of Shiv Raj Singh

Directorship timeline

Open interactive timeline →
Devann Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shiv Raj Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shiv Raj Singh

Shiv Raj Singh currently holds 1 directorship: Devann Pharmaceuticals Private Limited (Director, since 10 Nov 2021, revenue ₹22.7 Lakh (FY 2025)).

Shiv Raj Singh was first appointed on 10 Nov 2021 as Director at Devann Pharmaceuticals Private Limited.

The current boards of Shiv Raj Singh's companies include Gaurav Agarwal (Devann Pharmaceuticals Private Limited), Sumit Sharma (Devann Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available